Special Combination of BBI608 and Pembrolizumab
Clinical trial NCT02851004 · TERMINATED
Trial details
- NCT number
- NCT02851004
- Sponsor
- Takayuki Yoshino
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2020-02-03
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.